Marie Wickstrom Lindholm

Title: Marie Wickstrom Lindholm: Innovator in Antisense Oligomers

Introduction

Marie Wickstrom Lindholm is a prominent inventor based in Hørsholm, Denmark. She has made significant contributions to the field of medical research, particularly in the development of antisense oligomers targeting PCSK9. With a total of 8 patents to her name, her work has the potential to impact the treatment of various medical disorders.

Latest Patents

One of her latest patents focuses on antisense oligomers that target Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) mRNA in cells. This invention leads to reduced expression of PCSK9, which is beneficial for managing hypercholesterolemia and related disorders. The innovative approach of using oligomeric compounds and conjugates to address these medical issues showcases her expertise and dedication to advancing healthcare solutions.

Career Highlights

Marie Wickstrom Lindholm is currently associated with Roche Innovation Center Copenhagen A/S, where she continues to push the boundaries of medical research. Her work at Roche has allowed her to collaborate with leading experts in the field, further enhancing her contributions to innovative healthcare solutions.

Collaborations

Some of her notable coworkers include Niels Fisker Nielsen and Nanna Albæk. Their collaborative efforts have played a crucial role in the development of groundbreaking research and innovations in the medical field.

Conclusion

Marie Wickstrom Lindholm is a trailblazer in the field of antisense oligomers, with a strong focus on addressing critical medical challenges. Her contributions through her patents and work at Roche Innovation Center Copenhagen A/S highlight her commitment to improving healthcare outcomes.